131 related articles for article (PubMed ID: 3367085)
1. Hepatic 7 alpha-dehydroxylation of bile acid intermediates, and its significance for the pathogenesis of cerebrotendinous xanthomatosis.
Skrede S; Buchmann MS; Björkhem I
J Lipid Res; 1988 Feb; 29(2):157-64. PubMed ID: 3367085
[TBL] [Abstract][Full Text] [Related]
2. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
Salen G; Shefer S; Tint GS
Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of 7 alpha-hydroxy-4-cholesten-3-one and cholesta-4,6-dien-3-one in patients with cerebrotendinous xanthomatosis: effect of treatment with chenodeoxycholic acid.
Björkhem I; Skrede S; Buchmann MS; East C; Grundy S
Hepatology; 1987; 7(2):266-71. PubMed ID: 3557306
[TBL] [Abstract][Full Text] [Related]
4. A novel route for the biosynthesis of cholestanol, and its significance for the pathogenesis of cerebrotendinous xanthomatosis.
Skrede S; Bjørkhem I
Scand J Clin Lab Invest Suppl; 1985; 177():15-21. PubMed ID: 3865344
[TBL] [Abstract][Full Text] [Related]
5. Biosynthesis of cholestanol from intestinal 7 alpha-hydroxy-4-cholesten-3-one.
Skrede S; Björkhem I
J Biol Chem; 1982 Jul; 257(14):8363-7. PubMed ID: 7045120
[TBL] [Abstract][Full Text] [Related]
6. A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis.
Skrede S; Björkhem I; Buchmann MS; Hopen G; Fausa O
J Clin Invest; 1985 Feb; 75(2):448-55. PubMed ID: 3919058
[TBL] [Abstract][Full Text] [Related]
7. Isolation of 5 alpha-cholestane-3 beta, 7 alpha-diol from bile of patients with cerebrotendinous xanthomatosis. Inefficiency of this steroid as a precursor to cholestanol.
Björkhem I; Buchmann MS; Skrede S
Biochim Biophys Acta; 1983 Sep; 753(2):220-6. PubMed ID: 6412759
[TBL] [Abstract][Full Text] [Related]
8. Assay of intermediates in bile acid biosynthesis using isotope dilution--mass spectrometry: hepatic levels in the normal state and in cerebrotendinous xanthomatosis.
Björkhem I; Oftebro H; Skrede S; Pedersen JI
J Lipid Res; 1981 Feb; 22(2):191-200. PubMed ID: 7017048
[TBL] [Abstract][Full Text] [Related]
9. Studies of the mechanism of the increased biosynthesis of cholestanol in cerebrotendinous xanthomatosis. The activity of delta 5-3 beta-hydroxysteroid dehydrogenase.
Buchmann MS; Björkhem I; Fausa O; Skrede S
Scand J Gastroenterol; 1985 Dec; 20(10):1262-6. PubMed ID: 3868019
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of the cholestanol precursor cholesta-4,6-dien-3-one in different tissues.
Buchmann MS; Björkhem I; Skrede S
Biochim Biophys Acta; 1987 Nov; 922(2):111-7. PubMed ID: 3676336
[TBL] [Abstract][Full Text] [Related]
11. On the mechanism of biosynthesis of cholestanol from 7 alpha-hydroxycholesterol.
Buchmann MS; Björkhem I; Lund AM; Skrede S
Scand J Clin Lab Invest Suppl; 1986; 184():41-6. PubMed ID: 3109015
[TBL] [Abstract][Full Text] [Related]
12. On the substrate specificity of human CYP27A1: implications for bile acid and cholestanol formation.
Norlin M; von Bahr S; Bjorkhem I; Wikvall K
J Lipid Res; 2003 Aug; 44(8):1515-22. PubMed ID: 12777473
[TBL] [Abstract][Full Text] [Related]
13. Cerebrotendinous xanthomatosis: defective liver mitochondrial hydroxylation of chenodeoxycholic acid precursors.
Oftebro H; Björkhem I; Størmer FC; Pedersen JI
J Lipid Res; 1981 May; 22(4):632-40. PubMed ID: 6792308
[TBL] [Abstract][Full Text] [Related]
14. Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge.
Björkhem I; Hansson M
Biochem Biophys Res Commun; 2010 May; 396(1):46-9. PubMed ID: 20494109
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of cholestanol from bile acid intermediates in the rabbit and the rat.
Skrede S; Björkhem I; Buchmann MS; Midtvedt T
J Biol Chem; 1985 Jan; 260(1):77-81. PubMed ID: 3917436
[TBL] [Abstract][Full Text] [Related]
16. Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX.
Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Leitersdorf E; Tint GS; Erickson SK; Tanaka N; Shefer S
J Lipid Res; 2001 Feb; 42(2):291-300. PubMed ID: 11181760
[TBL] [Abstract][Full Text] [Related]
17. The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis.
Salen G; Grundy SM
J Clin Invest; 1973 Nov; 52(11):2822-35. PubMed ID: 4355999
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis of bile acids in cerebrotendinous xanthomatosis. Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26.
Salen G; Shefer S; Tint GS; Nicolau G; Dayal B; Batta AK
J Clin Invest; 1985 Aug; 76(2):744-51. PubMed ID: 4031069
[TBL] [Abstract][Full Text] [Related]
19. On the mechanism of accumulation of cholestanol in the brain of mice with a disruption of sterol 27-hydroxylase.
Båvner A; Shafaati M; Hansson M; Olin M; Shpitzen S; Meiner V; Leitersdorf E; Björkhem I
J Lipid Res; 2010 Sep; 51(9):2722-30. PubMed ID: 20511491
[TBL] [Abstract][Full Text] [Related]
20. Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism.
Salen G
Ann Intern Med; 1971 Dec; 75(6):843-51. PubMed ID: 5134895
[No Abstract] [Full Text] [Related]
[Next] [New Search]
